Noah Wald-Dickler, MD, FACP, discusses the safety and efficacy of oral transition therapy, challenges in antimicrobial stewardship, and evidence-based alternatives presented at SHEA 2024.
Antimicrobial resistance
(Adobe Stock, unknown)
Focusing on antimicrobial stewardship, his research emphasizes the safety and efficacy of oral transition therapy. With extensive experience and numerous publications, Wald-Dickler advocates for evidence-based practices to address challenges in infection prevention and control.
Through his presentation—and the many other times he has given the same presentation throughout the world—he aimed to challenge entrenched dogmas and promote evidence-based modern approaches, highlighting the importance of oral therapy over traditional IV methods. This ultimately contributed to improved patient outcomes and the advancement of the field of infectious diseases.
ICT: What inspired you to choose the topics for your presentation at the SHEA conference this year?
Noah Wald-Dickler, MD, FACP
(Courtesy of Noah Wald-Dickler, MD, FACP)
Noah Wald-Dickler, MD, FACP: Antimicrobial stewardship is core to what we all do in infection prevention. Our group at LA General has published several studies on the safety and efficacy of oral transition therapy, and SHEA is a great venue to spread the mantra of "Oral is the New IV."
ICT: Could you elaborate on the key points or takeaways you aimed to deliver to the audience during your session?
NW-D: The key point is that compared to prolonged IV therapy, oral transition therapy is safe and just as clinically effective. It's also intrinsically safer for patients and allows them to be discharged sooner from the hospital. Now that we have an abundance of randomized controlled trials comparing all IV therapy vs oral transition therapy, clinicians really should be using oral transition regimens supported by high-quality randomized control trials.
ICT: Were there any surprising insights or findings that emerged while preparing for your presentation, and if so, how did they impact your approach?
NW-D: Not really. I've given one version or another of this talk several times now (including recently in Colombia in Spanish).
ICT: In your opinion, what are the most significant challenges that epidemiologists and other infection prevention personnel face today, and how does your presentation address these challenges?
NW-D: Unfortunately, old dogmas persist, even when the evidence points to the contrary. The "Oral is the New IV" and "Shorter is Better" movements in antimicrobial stewardship are key in dispelling these myths by providing modern, evidence-based alternatives to decades of dogma.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.